Preventive effects of rebamipide on NSAID-induced gastric mucosal injury and reduction of gastric mucosal blood flow in healthy volunteers

Digestive Diseases and Sciences

Volumn 52, Issue 8, 2007, Pages 1776-1782

  Kim, Hyung Keun ^a,b   Kim, Jin Il ^c   Kim, Jae Kwang ^c   Han, Joon Yeol ^c   Park, Soo Heon ^c   Choi, Kyu Yong ^a,d   Chung, In Sik ^a,c  

^a The Catholic University of Korea   (South Korea)

^b Uijeongbu St Mary's Hospital   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Our Lady Mercy Hospital   (South Korea)

Author keywords

Gastric mucosal blood flow; Modified Lanza score; Nonsteroidal anti inflammatory drug; Rebamipide

Indexed keywords

IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; REBAMIPIDE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOATING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIGASTRIC PAIN; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; MALE; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; SATIETY; SCORING SYSTEM; SIDE EFFECT; STOMACH ANTRUM; STOMACH BLOOD FLOW; STOMACH MUCOSA LESION; STOMACH ULCER; VOLUNTEER;

ADULT; AGED; ALANINE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; FEMALE; GASTRIC MUCOSA; HUMANS; IBUPROFEN; MALE; MIDDLE AGED; QUINOLONES;

EID: 34247204039     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9367-y     Document Type: Article

References (27)

1. Anonymous (1992) Anti-arthritis medication usage: United States 199l. Stat Bull Metrop Insur Co 73:25-34
2. Henry D, Lim LL, Garcia Rodriguez LA et al (1996) Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 312:1563-1566
3. Gabriel SE, Jaakkimainen L, Bombardier C (1991) Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 115:787-796
4. Bollini P, Garcia Rodriguez LA, Perez Gutthann S, Walker AM (1992) The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease. Arch Intern Med 152:1289-1295
5. Ashley SW, Sonnenschein LA, Cheung LY (1985) Focal gastric mucosal blood flow at the site of aspirin-induced ulceration. Am J Surg 149:53-59
6. Kitahora T, Guth PH (1987) Effect of aspirin plus hydrochloric acid on the gastric mucosal microcirculation. Gastroenterology 93:810-817
7. Gana TJ, Huhlewych R, Koo J (1987) Focal gastric mucosal blood flow in aspirin-induced ulceration. Ann Surg 205:399-403
8. Del Soldato P, Foschi D, Benoni G, Scarpignato C (1985) Oxygen free radicals interact with indomethacin to cause gastrointestinal injury. Agents Actions 17:484-488
9. Vaananen PM, Meddings JB, Wallace JL (1991) Role of oxygen-derived free radicals in indomethacin-induced gastric injury. Am J Physiol 261:G470-G475
10. Murakami K, Okajima K, Uchiba M et al (1997) Rebamipide attenuates indomethacin-induced gastric mucosal lesion formation by inhibiting activation of leukocytes in rats. Dig Dis Sci 42:319-325
11. Kleine A, Kluge S, Peskar BM (1993) Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats. Dig Dis Sci 38:1441-1449
12. Oka S, Ogino K, Hobara T et al (1991) Effects of various mucosal protective drugs on diethyldithiocarbamate-induced antral ulcer in rats. Eur J Pharmacol 197:99-102
13. Lanza FL, Royer GL Jr, Nelson RS et al (1981) A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti-inflammatory agents on the gastric and duodenal mucosa. Am J Gastroenterol 75:17-21
14. Lanza FL (1984) Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. Am J Med 77:19-24
15. Naito Y, Yoshikawa T, Iinuma S, Yagi N et al (1998) Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study. Dig Dis Sci 43 (Suppl 9):83S-89S
16. Murakami K, Okajima K, Harada N, Isobe H, Okabe H (1998) Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats. Dig Dis Sci 43(Suppl 9):139S-142S
17. Konturek JW, Dembinski A, Stoll R, Domschke W, Konturek SJ (1994) Mucosal adaptation to aspirin induced gastric damage in humans. Studies on blood flow, gastric mucosal growth and neutrophil activation. Gut 35:1197-1204
18. Konturek SJ, Konturek JW (1994) Gastric adaptation: basic and clinical aspects. Digestion 55:131-138
19. Lipscomb GR, Wallis N, Armstrong G, Goodman MJ, Rees WD (1995) Gastric mucosal adaptation to etodolac and naproxen. Aliment Pharmacol Ther 9:379-385
20. Lipscomb GR, Rees WDW (1996) Gastric mucosal injury and adaptation to oral and rectal administration of naproxen. Aliment Pharmacol Ther 10:133-138
21. Wallace JL, Granger DN (1992) Pathogenesis of NSAID-gastropathy: are neutrophils the culprits? Trends Pharmacol Sci 13:129-131
22. Wallace JL (1997) Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroeterology 112:1000-1016
23. Guslandi M, Foppa L, Fanti L, Sorghi M (1999) Nonsteroidal anti-Inflammatory drugs and gastric mucosal blood flow. J Clin Gastroenterol 28:258-260
24. 2 metabolism. Gut 33:164-169
25. Chan FK, Sung JJ (2000) How does Helicobacter pylori infection interact with non-steroidal anti-inflammatory drugs? Baillieres Clin Gastroenterol 14:161-172
26. Wu CY, Poon SK, Chen GH, Chang CS, Yeh HZ (1999) Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding. Scand J Gastroenterol 34:234-237
27. Okan A, Tankurt E, Aslan BU, Akpinar H, Simsek I, Gonen O (2003) Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcers: A case-control study. J Gastroenterol Hepatol 18:18-25